Lixte Biotechnology Holdings Inc (LIXT)

Lixte Biotechnology Holdings Inc 주식(LIXT)의 최신 뉴스

LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer” - GlobeNewswire

GlobeNewswire

LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer” - Yahoo Finance

Yahoo Finance

Mixed Shelf Filing Gives Micro Cap Delayed Boost - The Globe and Mail

The Globe and Mail

Lixte (LIXT) Stock Jumps On Positive Feedback For Lead Drug Candidate – News IMC - News IMC

News IMC

Gold Moves Higher; Velo3D Shares Plummet

Benzinga

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Crude Oil Edges Lower; PaySign Shares Spike Higher

Benzinga

Dow Jumps Over 200 Points; UniFirst Posts Downbeat Earnings

Benzinga

Gold Moves Higher; Velo3D Shares Plummet - Cintas (NASDAQ:CTAS), Direct Digital Holdings (NASDAQ:DRCT) - Benzinga

Benzinga

LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments

GlobeNewswire Inc.

LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy ... - GlobeNewswire

GlobeNewswire

Professor René Bernards to Present New Pre-Clinical Data on LIXTE's LB-100 at Joint Conference of European and ... - Yahoo Finance

Yahoo Finance

LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI

GlobeNewswire Inc.

LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI - GlobeNewswire

GlobeNewswire

Lixte CEO Takes On a New Course - Los Angeles Business Journal

Los Angeles Business Journal

First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial

GlobeNewswire Inc.

LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations - GlobeNewswire

GlobeNewswire

LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration - GlobeNewswire

GlobeNewswire

LIXTE Biotechnology Holdings Announces the Passing of its Founder, John S. Kovach - GlobeNewswire

GlobeNewswire

LIXTE Appoints Bas van der Baan as President and Chief Executive Officer - Yahoo Finance

Yahoo Finance

LIXTE Biotechnology Holdings, Inc. Regains Compliance with Nasdaq Continued Listing Requirements - Yahoo Finance UK

Yahoo Finance UK

Why Is Lixte Biotech (LIXT) Stock Down 29% Today? - InvestorPlace

InvestorPlace

Kovach, John - Moneyshow.com

Moneyshow.com

Lixte Biotechnology Holdings, Inc. Announces Pricing of $5700000 Public Offering; Uplisting to Nasdaq Capital Market ... - GlobeNewswire

GlobeNewswire

LIXT Stock Price and Chart — NASDAQ:LIXT — TradingView - TradingView

TradingView

Lixte Biotechnology Begins Mini-IPO Plan (NASDAQ:LIXT) - Seeking Alpha

Seeking Alpha